I feel we will get some deal once some sort of cardio protection is confirmed in humans or even just after 1B trials are completed I don't think we will even get to P2 trials to be honest I think pharma will try snap us up and try offer 3 billion or there abouts at a early buyout stage before we do P2 to be honest that's what I'm tipping so they don't have to dig deeper that's a $25 SP.
why will they wait for P2 to be confirmed when we have had so many trials in the past that have been successful they will be happy to buy us early for $3 billion $25 a share and take the risk then pay $100 a share.
Some will kick and scream but I'll be extremely happy and grateful for that price.
Also the company will push it through I would imagine as who ever buys us out will be able to get it into patients quicker
that's what they will say.
I will vote YES for a $25 buyout at an early stage buyout why would I take the risk if something goes wrong
RAC Price at posting:
$1.17 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)